US HB4955 | 2019-2020 | 116th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on October 31 2019 - 25% progression, died in committee
Action: 2019-11-01 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on October 31 2019 - 25% progression, died in committee
Action: 2019-11-01 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To amend the Federal Food, Drug, and Cosmetic Act to clarify the meaning of a new chemical entity.
Title
Protecting Access to Safe and Effective Medicines Act of 2019
Sponsors
| Rep. Eliot Engel [D-NY] | Rep. Brett Guthrie [R-KY] | Rep. Kurt Schrader [D-OR] | Rep. Richard Hudson [R-NC] |
History
| Date | Chamber | Action |
|---|---|---|
| 2019-11-01 | House | Referred to the Subcommittee on Health. |
| 2019-10-31 | House | Referred to the House Committee on Energy and Commerce. |
| 2019-10-31 | House | Introduced in House |
Same As/Similar To
SB1636 (Related) 2020-12-15 - Held at the desk.
Subjects
Administrative law and regulatory procedures
Chemistry
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Health
Chemistry
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Health
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/116th-congress/house-bill/4955/all-info |
| Text | https://www.congress.gov/116/bills/hr4955/BILLS-116hr4955ih.pdf |
